Trials / Completed
CompletedNCT00890045
Hemodialysis Reliable Outflow (HeRO) Vascular Access Patency Study
A Comparison Between the HeRO® Graft and Conventional Arteriovenous Grafts in Hemodialysis Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 72 (actual)
- Sponsor
- Merit Medical Systems, Inc. · Industry
- Sex
- All
- Age
- 22 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
Compare the HeRO Vascular Access Device to a conventional ePTFE graft.
Detailed description
The purpose of this study is to compare the HeRO Vascular Access Device to a conventional ePTFE graft. It is hypothesized that HeRO patency will be comparable to the conventional ePTFE graft control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | HeRO Vascular Access Device | HeRO Vascular Access Device |
| DEVICE | Conventional ePTFE hemodialysis graft | Conventional ePTFE hemodialysis graft |
Timeline
- Start date
- 2004-07-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2009-04-29
- Last updated
- 2024-01-29
- Results posted
- 2021-06-09
Locations
11 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00890045. Inclusion in this directory is not an endorsement.